(2) | (47) | " (5) | # (2) | $ (1) | 0 (43) | 1 (528) | 2 (598) | 3 (345) | 4 (27) | 5 (20) | 6 (14) | 7 (6) | 8 (3) | 9 (4) | < (49) | A (334) | B (70) | C (269) | D (140) | E (194) | F (157) | G (461) | H (72) | I (178) | J (46) | K (71) | L (86) | M (209) | N (154) | O (62) | P (276) | Q (10) | R (114) | S (496) | T (557) | U (133) | V (38) | W (306) | X (9) | Y (15) | Z (8) |   (1) | Д (1) | П (1) | С (1) | إ (1) | ‘ (2) | “ (1)
Title Last update
Annex G. GDF access to supplier information for WHO PQP and ERP assessed TB medicines ITB-Iplus/GDF-MED/2023/4 Mon, 08/28/2023 - 06:23
Annex H. Indicative non-binding estimated quantities ITB-Iplus/GDF-MED/2023/4 Mon, 08/28/2023 - 06:23
Annex K. Form for Requests for Clarifications or Complaints after ITB awarding ITB-Iplus/GDF-MED/2023/4 Mon, 08/28/2023 - 06:25
Access bedaquiline Wed, 08/30/2023 - 11:00
About 450,000 people estimated to have drug-resistant TB globally Wed, 09/06/2023 - 05:57
Archived procurement notices Fri, 09/08/2023 - 03:39
Annex A. Financial Bid Response Form ITB-Iplus/GDF-MED/2023/5 Fri, 09/08/2023 - 04:02
Annex B - List and technical specifications of products requested ITB-Iplus/GDF-MED/2023/5 Fri, 09/08/2023 - 04:05
Annex C. List of priority countries for TB medicines registration ITB-Iplus/GDF-MED/2023/5 Fri, 09/08/2023 - 04:08
Annex G. GDF access to supplier information for WHO PQP and ERP assessed TB medicines ITB-Iplus/GDF-MED/2023/5 Fri, 09/08/2023 - 04:12
Annex H. Indicative non-binding estimated quantities ITB-Iplus/GDF-MED/2023/5 Fri, 09/08/2023 - 04:14
Annex K. Form for Requests for Clarifications or Complaints after ITB awarding ITB-Iplus/GDF-MED/2023/5 Fri, 09/08/2023 - 04:17
Ahnaf Tahmed Faiz Mon, 09/11/2023 - 06:57
African Pre-meeting in Preparation for the UNHLM on TB Fri, 09/15/2023 - 06:12
Access pretomanid Mon, 09/18/2023 - 10:46
A Deadly Divide: TB Commitments vs TB Realities Final Report 2020 (Arabic) Tue, 09/19/2023 - 13:01
A Deadly Divide: TB Commitments vs TB Realities Final Report 2020 (English) Tue, 09/19/2023 - 13:02
A Deadly Divide: TB Commitments vs TB Realities Final Report 2020 (Portuguese) Tue, 09/19/2023 - 13:02
A Deadly Divide: TB Commitments vs TB Realities Final Report 2020 (Spanish) Tue, 09/19/2023 - 13:03
A Deadly Divide: TB Commitments vs TB Realities Final Report 2020 (Russian) Tue, 09/19/2023 - 13:03
A Deadly Divide: TB Commitments vs TB Realities Final Report 2020 (French) Tue, 09/19/2023 - 13:04
A Deadly Divide: Priorities to Close the Deadly Divide Final Report 2023 (English) Tue, 09/19/2023 - 13:06
A Deadly Divide: Priorities to Close the Deadly Divide Final Report 2023 (French) Tue, 09/19/2023 - 13:14
A Deadly Divide: Priorities to Close the Deadly Divide Final Report 2023 (Portuguese) Tue, 09/19/2023 - 13:16
A Deadly Divide: Priorities to Close the Deadly Divide Final Report 2023 (Russian) Tue, 09/19/2023 - 13:17
A Deadly Divide: Priorities to Close the Deadly Divide Final Report 2023 (Hindi) Tue, 09/19/2023 - 13:18
A Deadly Divide: Priorities to Close the Deadly Divide Final Report 2023 (Spanish) Tue, 09/19/2023 - 13:22
A Deadly Divide: Priorities to Close the Deadly Divide 2 Page Summary 2023 (English) Tue, 09/19/2023 - 13:28
A Deadly Divide: Priorities to Close the Deadly Divide 2 Page Summary 2023 (French) Tue, 09/19/2023 - 13:31
A Deadly Divide: Priorities to Close the Deadly Divide 2 Page Summary 2023 (Spanish) Tue, 09/19/2023 - 13:32
A Deadly Divide: Priorities to Close the Deadly Divide 2 Page Summary 2023 (Russian) Tue, 09/19/2023 - 13:32
Aperçu des modules de formation Truenat Wed, 09/20/2023 - 06:42
Access TPT Fri, 09/22/2023 - 04:45
Asia-Pacific (AP) Risign: Mon, 09/25/2023 - 06:50
Access delamanid Thu, 10/12/2023 - 12:13
Alex Durena Presentation Tue, 10/17/2023 - 04:48